Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 4:54 AM UTC
| NCT Number | NCT07341867 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 90 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Andrew Hantel, MD |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT07341867 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Andrew Hantel, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07341867 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07341867 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.